HuGE Literature Finder
Records
1
-
5
Frequencies of Genetic Polymorphisms of Clinically Relevant Gene-Drug Pairs in a German Psychiatric Inpatient Population. Pharmacopsychiatry 2020 Dec . Hahn Martina, Müller Daniel J, Roll Sibylle |
The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk-a European multicentre study on treatment-resistant major depressive disorder. European archives of psychiatry and clinical neuroscience 2012 Oct . Höfer P, Schosser A, Calati R, Serretti A, Massat I, Kocabas NA, Konstantinidis A, Linotte S, Mendlewicz J, Souery D, Zohar J, Juven-Wetzler A, Montgomery S, Kasper S |
Physiogenomic analysis of CYP450 drug metabolism correlates dyslipidemia with pharmacogenetic functional status in psychiatric patients. Biomarkers in medicine 2011 Aug 5 (4): 439-49. Ruaño Gualberto, Villagra David, Szarek Bonnie, Windemuth Andreas, Kocherla Mohan, Gorowski Krystyna, Berrezueta Christopher, Schwartz Harold I, Goethe Jo |
Increased carrier prevalence of deficient CYP2C9, CYP2C19 and CYP2D6 alleles in depressed patients referred to a tertiary psychiatric hospital. Personalized medicine 2008 Nov 5 (6): 579-587. Ruaño Gualberto, Villagra David, Rahim Umme Salma, Windemuth Andreas, Kocherla Mohan, Bower Bruce, Szarek Bonnie L, Goethe John |
CYP2C9 gene and susceptibility to major depressive disorder. The pharmacogenomics journal 2003 3 (5): 300-2. LLerena A, Berecz R, Dorado P, González A P, Peñas-LLedó E M, De La Rubia |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: